Qiuzi Li

Discovery of Novel Bicyclic Phenylselenyl-Containing Hybrids: An Orally Bioavailable, Potential, and Multiacting Class of Estrogen Receptor Modulators against Endocrine-Resistant Breast Cancer.

Zhiye Hu, Hai-Bing Zhou, Jian Huang, 2022, Journal of medicinal chemistry.

Ligand-induced native G-quadruplex stabilization impairs transcription initiation

Jian Huang, Kaiwei Liang, Pingping Fang, 2021, Genome research.

Genomic profiling of native R loops with a DNA-RNA hybrid recognition sensor

Jian Huang, Kaiwei Liang, Pingping Fang, 2021, Science Advances.

OBHS Drives Abnormal Glycometabolis Reprogramming via GLUT1 in Breast Cancer

Jian Huang, Qiuzi Li, Pingping Fang, 2023, International journal of molecular sciences.

CDK12 and Integrator-PP2A complex modulates LEO1 phosphorylation for processive transcription elongation

Kaiwei Liang, Ruijing Xiao, Honghong Wang, 2023, Science advances.

Identification of Novel Dual-Target Estrogen Receptor α Degraders with Tubulin Inhibitory Activity for the Treatment of Endocrine-Resistant Breast Cancer.

Wentao Ning, Zhiye Hu, Lilan Xin, 2023, Journal of medicinal chemistry.

Discovery of a Novel Class of PROTACs as Potent and Selective Estrogen Receptor α Degraders to Overcome Endocrine-Resistant Breast Cancer In Vitro and In Vivo.

Zhiye Hu, Jian Huang, C. Dong, 2023, Journal of medicinal chemistry.